Inhibition of STAT3-NF-κB pathway facilitates SSPH I-induced ferroptosis in HepG2 cells
Medical Oncology · 2024
DOI: 10.1007/s12032-024-02425-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, 2024. Verfasst von Yuewen Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi University of Chinese Medicine, Nanning, China. sunyw@gxtcmu.edu.cn. Hauptthemen laut MEDLINE: Ferroptosis, STAT3 Transcription Factor, NF-kappa B, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Province, Qihuang Project Team of Guangxi University of Chinese Medicine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi University of Chinese Medicine, Nanning, China. sunyw@gxtcmu.edu.cn.
- Guangxi Vocational University of Agriculture, Nanning, China.
- Guangxi University of Chinese Medicine, Nanning, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
- Qihuang Project Team of Guangxi University of Chinese Medicine
- Young talents in Gui Pai Xing lin of Guangxi University of Chinese Medicine
Zitieren
APA
Sun, Y., Huang, D., Li, J., Zhou, Y., Zhou, G., & Chen, Q. (2024). Inhibition of STAT3-NF-κB pathway facilitates SSPH I-induced ferroptosis in HepG2 cells. Medical Oncology. https://doi.org/10.1007/s12032-024-02425-2
Vancouver
Sun Y, Huang D, Li J, Zhou Y, Zhou G, Chen Q. Inhibition of STAT3-NF-κB pathway facilitates SSPH I-induced ferroptosis in HepG2 cells. Medical Oncology. 2024. doi:10.1007/s12032-024-02425-2
BibTeX
@article{Sun2024,
author = {Sun, Yuewen and Huang, Dan and Li, Jianzhe and Zhou, Ying and Zhou, Guangyu and Chen, Qingjie},
title = {Inhibition of STAT3-NF-κB pathway facilitates SSPH I-induced ferroptosis in HepG2 cells},
journal = {Medical Oncology},
year = {2024},
doi = {10.1007/s12032-024-02425-2}
}
EUVIMED